Form 4: HilleVax Director Julie Gerberding Acquires 22,500 Stock Options

Julie Gerberding, a director of HilleVax, Inc., acquired 22,500 stock options on June 6, 2024, as part of the company's non-employee director compensation program.

Summary

• On June 6, 2024, Julie L. Gerberding, a director of HilleVax, Inc. (HLVX), was granted 22,500 stock options.
• The options were granted as part of the company's non-employee director compensation program.
• The exercise price of the stock options is $13.75.
• The options will vest on the earlier of the first anniversary of the grant date (June 6, 2025) or the next annual meeting of stockholders, contingent upon continued service on the board.
• The options expire on June 5, 2034.

Sentiment

Score: 7

Explanation: The document reflects a standard corporate practice (granting stock options to a director), suggesting a neutral to slightly positive sentiment as it aligns director interests with shareholders.

Positives

• The grant of stock options aligns the director's interests with those of the shareholders.
• The vesting schedule incentivizes continued service on the board of directors.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting schedule of the options.

Industry Context

Stock option grants are a common form of compensation for directors of publicly traded companies, aligning their interests with shareholders and incentivizing company performance.

Comparison to Industry Standards

• Director compensation packages, including stock options, are typical in the biotechnology industry to attract and retain qualified board members.
• Companies like Moderna and BioNTech also utilize stock options as part of their director compensation packages.
• The vesting schedule and exercise price are generally in line with industry standards for similar-stage companies.

Stakeholder Impact

• Shareholders: The grant of stock options aligns the director's interests with those of the shareholders, potentially leading to better corporate governance and decision-making.
• Employees: The grant of stock options to a director can boost employee morale by demonstrating that the company values its leadership.

Key Dates

Keywords

HilleVax, HLVX, Director, Julie Gerberding, Stock Options, Compensation, Form 4, Beneficial Ownership